These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30497875)

  • 1. Clinicopathological characteristics of non-functioning cystic pancreatic neuroendocrine tumors.
    Nakashima Y; Ohtsuka T; Nakamura S; Mori Y; Nakata K; Miyasaka Y; Ishigami K; Matsuda R; Oda Y; Nakamura M
    Pancreatology; 2019 Jan; 19(1):50-56. PubMed ID: 30497875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic pancreatic neuroendocrine tumors: A more favorable lesion?
    Carr RA; Bletsis P; Roch AM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
    Pancreatology; 2019 Mar; 19(2):372-376. PubMed ID: 30704851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic pancreatic neuroendocrine tumors: outcomes of preoperative endosonography-guided fine needle aspiration, and recurrence during long-term follow-up.
    Ridtitid W; Halawi H; DeWitt JM; Sherman S; LeBlanc J; McHenry L; Coté GA; Al-Haddad MA
    Endoscopy; 2015 Jul; 47(7):617-25. PubMed ID: 25763832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic pancreatic neuroendocrine tumors: A distinctive subgroup with indolent biological behavior? A systematic review and meta-analysis.
    Zhu JK; Wu D; Xu JW; Huang X; Jiang YY; Edil BH; Li M; Hu SY; Zhan HX
    Pancreatology; 2019 Jul; 19(5):738-750. PubMed ID: 31160191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic Pancreatic Neuroendocrine Tumors Represent a Distinct Clinical Entity with Less Aggressive Biological Behaviors.
    Cheng Y; Wu D; Wang L; Liu H; Xiong Y; Xu J; Hu S; Zhan H
    J Surg Res; 2021 Apr; 260():134-140. PubMed ID: 33340866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features and long-term prognosis of purely cystic pancreatic neuroendocrine tumors: A single-center experience.
    Ren SJ; Wang X; Ke NW; Tan QQ; Yang F; Yao WQ; Tan CL; Liu XB
    Asian J Surg; 2023 Feb; 46(2):774-779. PubMed ID: 35850904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
    Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
    Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors.
    Ge W; Zhou D; Xu S; Wang W; Zheng S
    Int J Surg; 2017 Mar; 39():127-134. PubMed ID: 28137555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study.
    Zhu LM; Tang L; Qiao XW; Wolin E; Nissen NN; Dhall D; Chen J; Shen L; Chi Y; Yuan YZ; Ben QW; Lv B; Zhou YR; Bai CM; Chen J; Song YL; Song TT; Lu CM; Yu R; Chen YJ
    Medicine (Baltimore); 2016 Feb; 95(7):e2836. PubMed ID: 26886644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
    Tsutsumi K; Ohtsuka T; Mori Y; Fujino M; Yasui T; Aishima S; Takahata S; Nakamura M; Ito T; Tanaka M
    J Gastroenterol; 2012 Jun; 47(6):678-85. PubMed ID: 22350698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of solid-pseudopapillary tumors of the pancreas from pancreatic neuroendocrine tumors by using endoscopic ultrasound.
    Liu Y; Shi S; Hua J; Xu J; Zhang B; Liu J; Yang XJ; Yu XJ
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):947-953. PubMed ID: 32144073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes.
    Okuwaki K; Kida M; Mikami T; Yamauchi H; Imaizumi H; Miyazawa S; Iwai T; Takezawa M; Saegusa M; Watanabe M; Koizumi W
    Cancer; 2013 Dec; 119(23):4094-102. PubMed ID: 24022344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
    Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
    ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors.
    Song KB; Kim SC; Kim JH; Seo DW; Hong SM; Park KM; Hwang DW; Lee JH; Lee YJ
    Pancreas; 2016 Feb; 45(2):187-92. PubMed ID: 26474434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
    Zhou B; Fang B; Yan S; Wang W
    Clin Lab; 2017 Jul; 63(7):1251-1259. PubMed ID: 28792692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of endoscopic ultrasound (EUS)/endoscopic ultrasound--fine needle aspiration (EUS-FNA) cytology in solid and cystic pancreatic neuroendocrine tumours.
    Mitra V; Nayar MK; Leeds JS; Wadehra V; Haugk B; Scott J; Charnley RM; Oppong KW
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):69-75. PubMed ID: 25822436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors.
    Makris EA; Cannon JGD; Norton JA; Lopez-Aguiar AG; Dillhoff M; Beal E; Idrees K; Smith PM; Rocha FG; Kanji Z; Cho C; Beems M; Weber S; Fisher A; Krasnick BA; Fields RC; Maithel SK; Poultsides GA
    Ann Surg Oncol; 2023 Apr; 30(4):2424-2430. PubMed ID: 36434481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Hormonal Expression Patterns Between Primary Pancreatic Neuroendocrine Tumors and Metastatic Sites.
    Kimura H; Ohtsuka T; Fujimoto T; Date K; Matsunaga T; Cases AI; Abe A; Mizuuchi Y; Miyasaka Y; Ito T; Oda Y; Nakamura M; Tanaka M
    Pancreas; 2016 Aug; 45(7):947-52. PubMed ID: 26684862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.
    Luo G; Liu Z; Guo M; Jin K; Xiao Z; Liu L; Liu C; Xu J; Ni Q; Long J; Yu X
    Pancreatology; 2015; 15(5):519-524. PubMed ID: 26365059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.